triclabendazole sulfoxide has been researched along with Fasciola Infection in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Beltrán, JF; Fonseca-Salamanca, F; Olivares-Ferretti, P; Salazar, LA | 1 |
| Brennan, GP; Fairweather, I; Hoey, E; Meaney, M; Savage, J; Trudgett, A | 1 |
| Alvarez, L; Ceballos, L; Fairweather, I; Lanusse, C; Moreno, L | 1 |
| Alvarez, L; Ceballos, L; Fairweather, I; Lanusse, C; Moreno, L; Shaw, L | 1 |
| Alvarez, LI; Brennan, GP; Devine, C; Fairweather, I; Hoey, E; Lanusse, CE; Trudgett, A | 1 |
| Braissant, O; Keiser, J; Kirchhofer, C; Manneck, T | 1 |
| Boray, JC; Brennan, GP; Fairweather, I; Fletcher, H; Hoey, EM; McKinstry, B; Trudgett, A; Walker, SM | 1 |
| Lanusse, C; Lifschitz, A; Pis, A; Sallovitz, J; Virkel, G | 1 |
8 other study(ies) available for triclabendazole sulfoxide and Fasciola Infection
| Article | Year |
|---|---|
Protein Modelling and Molecular Docking Analysis of Fasciola hepatica β-Tubulin's Interaction Sites, with Triclabendazole, Triclabendazole Sulphoxide and Triclabendazole Sulphone.
Topics: Animals; Anthelmintics; Benzimidazoles; Fasciola hepatica; Fascioliasis; Ligands; Molecular Docking Simulation; Sulfones; Triclabendazole; Tubulin | 2023 |
Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Benzimidazoles; Drug Resistance; Fasciola hepatica; Fascioliasis; Male; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Sulfoxides; Triclabendazole; Verapamil | 2013 |
Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Topics: Animals; Anthelmintics; Area Under Curve; Benzimidazoles; Bile; Fasciola hepatica; Fascioliasis; Liver; Male; Sheep; Sheep Diseases; Sulfones; Sulfoxides; Triclabendazole | 2014 |
Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
Topics: Animals; Anthelmintics; Area Under Curve; Benzimidazoles; Drug Resistance; Drug Therapy, Combination; Fasciola hepatica; Fascioliasis; Ivermectin; Male; Methimazole; Random Allocation; Sheep; Sheep Diseases; Sulfoxides; Triclabendazole | 2010 |
Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
Topics: Animals; Anthelmintics; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance; Drug Synergism; Fasciola hepatica; Fascioliasis; Golgi Apparatus; Ketoconazole; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Mitochondria; NADP; Rats; Rats, Sprague-Dawley; Sulfoxides; Triclabendazole | 2011 |
Isothermal microcalorimetry to study the activity of triclabendazole and its metabolites on juvenile and adult Fasciola hepatica.
Topics: Animals; Anthelmintics; Benzimidazoles; Calorimetry; Fasciola hepatica; Fascioliasis; Movement; Rats; Sulfones; Sulfoxides; Thermogenesis; Triclabendazole | 2013 |
Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
Topics: Animals; Antiplatyhelmintic Agents; Benzimidazoles; Cattle; Cattle Diseases; Fasciola hepatica; Fascioliasis; Female; Male; Parasitic Sensitivity Tests; Rats; Rats, Sprague-Dawley; Sheep; Sheep Diseases; Sulfoxides; Triclabendazole | 2004 |
Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep.
Topics: Animals; Animals, Newborn; Anthelmintics; Benzimidazoles; Enzyme Inhibitors; Fasciola hepatica; Fascioliasis; Male; Microsomes, Liver; Sheep; Sheep Diseases; Stomach, Ruminant; Sulfoxides; Triclabendazole | 2006 |